Skip to main content

Table 2 Resistance profiles and MDR frequency in E. coli isolates from equine faecal samples.

From: Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England

Abs

No. of faecal samples with at least one resistant E. coli; disc diffusion method (%)

No E. coli isolates exhibiting resistant phenotype

Proportion of isolates resistant by disc diffusion method, which were confirmed by MIC

No MDR-positive faecal samples

(% faecal samples)

AMP

89 (33.7%)

191

93.0%

57 (21.6%)

APR

1 (0.4%)

1

-

1 (0.4%)

NAL

36 (13.6%)

72

-

35 (13.3%)

CIP

28 (10.6%)

65

93.8%

28 (10.6%)

CHL

49 (18.6%)

102

100%

47 (17.8%)

FLO

9 (3.4%)

14

-

9 (3.4%)

TET

92 (34.8%)

198

93.4%

57 (21.6%)

TRI

135 (51.0%)

279

95.0%

57 (21.6%)

  1. Abbreviation: ABs, antimicrobials; AMP, ampicillin; APR, apramycin; NAL, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol; FLO, florfenicol; TET, tetracyclin; TRI, trimethoprim